IVAX Diagnostics Confirms That Its Policy is Not to Comment on Unusual Market Activity
June 14 2011 - 1:44PM
Business Wire
IVAX Diagnostics, Inc. (NYSE Amex:IVD) today reported that, in
light of the unusual market activity in its stock, the NYSE Amex
contacted IVAX Diagnostics in accordance with the NYSE Amex’s usual
practice. IVAX Diagnostics confirmed that its policy is not to
comment on unusual market activity.
About IVAX Diagnostics, Inc.
IVAX Diagnostics, Inc. (www.ivaxdiagnostics.com), headquartered
in Miami, Florida, is a fully integrated in vitro diagnostics
company that develops, manufactures and distributes in the United
States and internationally, proprietary diagnostic reagents, test
kits and instrumentation, primarily for autoimmune and infectious
diseases, through its three subsidiaries: Diamedix Corporation
(U.S.), Delta Biologicals S.r.l. (Europe), and ImmunoVision, Inc.
(U.S.).
Ivax Diagnostics (AMEX:IVD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ivax Diagnostics (AMEX:IVD)
Historical Stock Chart
From Jul 2023 to Jul 2024